15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Meritage Corporation, 4 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets span $58.00 to $93.00, a moderate spread. The average target of $78.00 sits 7% above the current $73.22. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.49 next quarter toward $6.48 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Hold
Strong Buy00%
Buy444%
Hold556%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Meritage Corporation.
As of Jul, 4 of 9 firms rate MTH a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MTH EPS & revenue forecast
EPS · NEXT QUARTER
$1.49
Range $1.40 – $1.54 · 3 analysts · -4% YoY
Next period, 3 analysts expect Meritage Corporation to earn $1.49 a share (range $1.40 – $1.54), versus $1.55 a year earlier. Full-year consensus is $5.00, growing to $6.48 the year after.
REVENUE · NEXT QUARTER
$1.5B
Range $1.5B – $1.5B · 3 analysts · +5% YoY
Revenue is expected to reach $1.5B (range $1.5B – $1.5B), +4.9% year-over-year. Full-year consensus is $5.5B, rising to $6.0B next year.
Top analysts covering Meritage Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MTH.
#1
Jay McCanless
Wedbush · Rank #7
Hold
$90.00+22.9% to target
Overall win rate
65%
+ Follow
#2
Jade Rahmani
Keefe, Bruyette & Woods · Rank #8
Hold
$76.00+3.8% to target
Overall win rate
59%
+ Follow
#3
Rafe Jadrosich
B of A Securities
Hold
$72.00-1.7% to target
Coverage
—
+ Follow
#4
John Lovallo
UBS
Buy
$86.00+17.5% to target
Coverage
—
+ Follow
#5
Stephen Kim
Evercore ISI Group
Hold
$69.00-5.8% to target
Coverage
—
+ Follow
MTH stock forecast FAQ
What is MTH's average 12-month price target?+
The 8 analysts with a live target average $78.00 for Meritage Corporation over the next 12 months, ranging from a $93.00 high to a $58.00 low.
Is MTH stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 9 analyst ratings, 4 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MTH?+
The Street-high target is $93.00 (Goldman Sachs), and the Street-low is $58.00 (JP Morgan). The average of all 8 active targets is $78.00.
How many Wall Street analysts cover MTH?+
9 analysts have an active rating on Meritage Corporation, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering MTH?+
Among analysts who currently cover MTH, Jay McCanless of Wedbush has the strongest overall Quantellect track record (Rank #7). Their current call is Hold with a $90.00 target.
What is Meritage Corporation's projected EPS for next quarter?+
The consensus estimate is $1.49 per share (range $1.40 – $1.54) across 3 analysts. Full-year EPS is projected at $5.00, rising to $6.48 the following year.
How much revenue is Meritage Corporation expected to report next quarter?+
Consensus revenue is $1.5B (range $1.5B – $1.5B). Full-year revenue is projected at $5.5B, growing to $6.0B next year.
Have analysts been upgrading or downgrading MTH lately?+
As of Jul, 4 of 9 firms rate MTH a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MTH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
